HealthDay on MSN

FDA approves subcutaneous Rybrevant Faspro for EGFR-mutated non-small cell lung cancer

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

Building Community and a Future in Neuroscience: The Journey of Essix Moser at Kennesaw State University

Essix Moser’s journey at Kennesaw State University (KSU) exemplifies this blend, showcasing how his involvement in hockey and neuroscience research has not only fostered community but also paved the ...

Accelerating next-generation drug discovery with click-based construction of PROTACs

In 2001, chemists K. Barry Sharpless, Hartmuth C. Kolb, and M. G. Finn introduced click chemistry, a concept in which organic ...